Western Europe
Western Europe Pharmaceuticals & Healthcare Insight provides country-by-country analysis of the key trends impacting the prescription, OTC and generic drugs industries across Western Europe. Western Europe Pharmaceuticals & Healthcare Insight includes competitive intelligence on the growth strategies of leading national and multinational companies, along with 5-year industry forecasts for each country. The service includes access to the very latest analysis, a searchable archive of articles and data and the ability to download PDFs of current and back issues.
›› To gain FREE online access for 14 days and to download a FREE PDF, click trial.
›› To receive 15 monthly pdf issues for the price of 12 and to gain immediate online access, click subscribe.
Ireland / Industry
BMI View: The Irish pharmaceutical industry contributed to 26% of total commodity exports in 2010, equating to US$31.03bn. R&D invesment in Ireland, combined with strong export-directed production, form a substantial proportion of GDP. As a result, it is BMI's view that price erosion mechanisms on medicines may temper Ireland's economic recovery. Price pressures on medicines...
2012-01-26Belgium / Industry
BMI View: Belgium's ageing population will have an unprecedented effect on the demand for pharmaceuticals and healthcare, which is a positive for companies operating in the industry....
2012-01-25Italy / Industry
BMI View: The Italian pharmaceutical market continues to be a challenging proposition and BMI believes the sector will be a target of further cost containment in 2012, particularly...
2012-01-24Industry Developments
Ireland
BMI View: The Irish pharmaceutical industry contributed to 26% of total commodity exports in 2010, equating to US$31.03bn. R&D invesment in Ireland, combined with strong export-directed...
2012-01-26Belgium
BMI View: Belgium's ageing population will have an unprecedented effect on the demand for pharmaceuticals and healthcare, which is a positive for companies operating in the industry....
2012-01-25Italy
BMI View: The Italian pharmaceutical market continues to be a challenging proposition and BMI believes the sector will be a target of further cost containment in 2012, particularly...
2012-01-24Spain
BMI View: Reinforcing BMI's view that companies with significant exposure to debt-ridden European markets will be hard hit by government austerity measures across the region, and in...
2012-01-20
